Last --
Change Today 0.00 / 0.00%
Volume 0.0
WNX On Other Exchanges
Symbol
Exchange
Venture
OTC US
All times are local (Market data is delayed by at least 15 minutes).

warnex inc (WNX) Snapshot

Open
--
Previous Close
--
Day High
--
Day Low
--
52 Week High
-- - --
52 Week Low
-- - --
Market Cap
--
Average Volume 10 Days
0.0
EPS TTM
--
Shares Outstanding
0.0
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for WARNEX INC (WNX)

Related News

No related news articles were found.

warnex inc (WNX) Related Businessweek News

No Related Businessweek News Found

warnex inc (WNX) Details

Warnex Inc. does not have significant operations. Prior to December 10, 2012, it provided bioanalytical services to the pharmaceutical and biotechnology industries. The company is headquartered in Laval, Canada.

warnex inc (WNX) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

warnex inc (WNX) Key Developments

Warnex Inc. Reports Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended September 30, 2013

Warnex Inc. reported unaudited consolidated earnings results for the third quarter and nine months ended September 30, 2013. For the quarter, the company’s revenue was $0 compared to $2,491,124 a year ago. Loss before undernoted items was $216,881 against earnings before undernoted items of $134,666 a year ago. Net loss and comprehensive loss was $216,881 or $0.01 per basic and diluted share against net earnings and comprehensive income of $134,666 or $0.00 per basic and diluted share a year ago. Net cash used in operations was $219,750 against $1,217,926 a year ago. Financial revenues amounted to $6,730 in the third quarter of 2013. For the nine months, the company’s revenue was $0 compared to $7,360,711 a year ago. Loss before undernoted items was $827,873 against $2,332,005 a year ago. Net loss and comprehensive loss was $827,873 or $0.03 per basic and diluted share against $2,333,035 or $0.09 per basic and diluted share a year ago. Net cash provided by operations was $483,160 against net cash used in operations of $625,705 a year ago. The company did not generate any sales, nor related cost of goods sold in the nine month period ended September 30, 2013, as a result of the sale of all of its operating divisions in 2012. Financial revenues amounted to $6,686 in the nine month period ended September 30, 2013. These decreases are due to the repayment in full of the company's debts in 2012.

Warnex Reviewinf Strategic Options For Remaining Assets

Warnex Inc. (TSXV:WNX.H) is reviewing strategic options for remaining assets. Following the repayment of its debts accomplished primarily from the sale of all of operating business units, the Board has been focused on reducing expenses, has undertaken a strategic review of its remaining assets and has initiated discussions with certain investment banking groups and other external parties. Warnex has also entered into discussions with its landlord with a view to terminating the long-term operating lease for its Laval, Quebec facilities as soon as reasonably practicable. The outcome of this review remains uncertain at this time, and the Board will update shareholders if and when any progress is made. Michael Singer, Chairman of Warnex said: "The Board continues to focus its efforts on reducing all operating costs, as evidenced by lower Q3-2013 general and administrative costs, and as such, the Company's financial position at September 30, 2013 and as of today continues to remain strong as the Board continues to evaluate all available strategic options. We look forward in reaching a conclusion to this ongoing process and making a recommendation to all Warnex shareholders as soon as reasonably possible."

Warnex Inc. Reports Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended June 30, 2013

Warnex Inc. reported unaudited consolidated earnings results for the second quarter and six months ended June 30, 2013. For the quarter, the company’s loss before undernoted items was $157,355 against $1,602,726 a year ago. Net loss and comprehensive loss was $157,355 or $0.01 per basic and diluted share against $1,603,756 or $0.06 per basic and diluted share a year ago. Net cash provided by operations was $871,279 against $901,601 a year ago. Financial revenues amounted to $1,474 in the second quarter of 2013, compared to financial expenses of $102,681 in the second quarter of 2012. For the six months, the company’s loss before undernoted items was $610,992 against $2,466,671 a year ago. Net loss and comprehensive loss was $610,992 or $0.02 per basic and diluted share against $2,467,701 or $0.10 per basic and diluted share a year ago. Net cash provided by operations was $702,910 against $592,221 a year ago. The company did not generate any sales, nor related cost of goods sold in the first half of 2013, as a result of the sale of all of its operating divisions in 2012.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
WNX:CN C$0.00 CAD 0.00

WNX Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Applied DNA Sciences Inc $0.11 USD -0.0005
DataDot Technology Ltd A$0.03 AUD +0.001
IDGlobal Corp $0.0006 USD 0.00
InkSure Technologies Inc $0.03 USD 0.00
Nanotech Security Corp C$1.65 CAD +0.01
View Industry Companies
 

Industry Analysis

WNX

Industry Average

Valuation WNX Industry Range
Price/Earnings 0.8x Not meaningful
Price/Sales 1.2x
Price/Book 0.5x
Price/Cash Flow 0.7x
TEV/Sales NM Not Meaningful

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact WARNEX INC, please visit www.warnex.ca. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.